Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Study of Potency of Cross-preconditioning to Prevent Ischemic-reperfusion Injury for Heart Transplantation Recipient

NCT03900390 is registered in ClinicalTrials.gov with Mengya Liang as lead sponsor.

NCT NCT03900390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03900390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Study of Potency of Cross-preconditioning to Prevent Ischemic-reperfusion Injury for Heart Transplantation Recipient
Lead sponsor
Mengya Liang
Phase
Not applicable
Overall status
Unknown status
Start date
July 7, 2017
Completion date
July 7, 2023
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic preconditioning